International Stem Cell Co. (OTCMKTS:ISCO – Get Free Report) shares passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.09 and traded as high as $0.12. International Stem Cell shares last traded at $0.12, with a volume of 22,500 shares traded.
International Stem Cell Stock Performance
The business has a fifty day moving average of $0.10 and a 200-day moving average of $0.09. The company has a market capitalization of $920,460.00, a P/E ratio of -1.44 and a beta of 0.05.
About International Stem Cell
International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally. It develops ISC- hpNSC, a neural stem cell program that has completed the Phase I clinical trial for the treatment of Parkinson's disease, as well as for treating stroke and traumatic brain injury.
Read More
- Five stocks we like better than International Stem Cell
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Institutional Investors Bet $1B on These 4 Stocks—Should You?
- How to Invest in Biotech Stocks
- One Must-Buy Stock and One to Avoid as Tariffs Shake the Market
- What Are the FAANG Stocks and Are They Good Investments?
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
Receive News & Ratings for International Stem Cell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Stem Cell and related companies with MarketBeat.com's FREE daily email newsletter.
